Andere talen Redx Pharma Plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:05 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12 ^GBX	-5,88%		+45,45%	-45,45%

19/04	Aandeelhouders Redx Pharma stemmen in met schrappingsplannen AIM	AN
02/04	Europa lager na paasweekend	AN

Redx Pharma shareholders approve AIM delisting plans	19/04
Redx Pharma Gets Shareholder Approval for Delisting from AIM	19/04
AIM-listed biotech firms face crunch votes on future	15/04
London loses yet another listed company as pharma company Redx goes private	03/04
Europe down after Easter holiday weekend	02/04
Redx Pharma plummets on plans to delist from AIM	02/04
FTSE 100 buoyed by UK manufacturing growth	02/04
AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist	02/04
Redx Pharma to Delist from London Bourse	02/04
Redx Pharma achieves milestone with dosing of first participant in Phase 1 clinical trial for RXC008	08/03
Redx Pharma Doses First Patient in Early-stage Trial of Inflammatory Bowel Disease Treatment	28/02
Redx Announces That First Participant Dosed in Phase 1 Trial of RXC008	28/02
AIM-listed Redx Pharma denies report that company is planning a US move	15/02
Redx Pharma clarifies not currently pursuing US listing	14/02
Redx Pharma Denies Media Report of Potential US Listing	14/02
Redx Pharma lands biggest deal to date with sale of KRAS inhibitor programme to Jazz Pharma	08/02
Jazz Pharmaceuticals to Acquire Redx Pharma's KRAS Inhibitor Program	07/02
Barratt and Smurfit Kappa bookend FTSE 100	07/02
RedX Pharma to Sell Kirsten Rat Sarcoma Virus Inhibitor Program to Jazz Pharmaceuticals	07/02
Redx Pharma shares skyrocket on deal to sell inhibitor program	07/02

Geen resultaten voor deze zoekopdracht